Based in Belfast, Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges!

Modius is the first product from Neurovalens which successfully launched in August 2017 on Indiegogo. Modius was designed to help improve the lives of people who struggle with their weight by using neuro-technology to help make weight loss easier. 

Awards:

Winner: Health Category at the Future Planet Awards 2019
Winner: Best New Concept or Innovation at the 2018 Yahoo Sports Technology Awards 
Winner: 2018 CES Innovation Award
Winner: Start-Up of the Year at the 2018 Digital DNA Awards
Winner: Start-Up World Cup Northern Ireland Winner 2018
Winner: Randox Health Weight Management Product of the Year 2018
Winner: Business Eye Small Business Awards Healthcare Business of the Year 2018
Winner: Innovative Business of the Year at the BEFTA 2018 awards 
Placed 3rd at 2018 CES Last Gadget Standing
Finalist for Med Tech Innovator Award
Finalist in the Best Investment in the Disruptive Tech category at the UK Business Angel Investment Awards 2019

Invest Northern Ireland

MedTech Innovator

Techstart Ventures

ACF Investors

IQ Capital

Growth Finance Fund

Wharton Asset Management Company Limited

Clarendon Fund Managers

Future Fund

Neurovalens

We're delighted to announce that the US Food & Drug Administration (FDA) have granted clearance for our Modius Sleep device for treating chronic insomnia.

Neurovalens CEO, Dr. Jason McKeown says:
“Having the Modius Sleep technology as a certified medical device for the treatment of chronic insomnia is a landmark step for the company as we focus on future growth in the U.S. market.”

READ MORE on this MassDevice article.
https://lnkd.in/eiymH8Vs

#medicaldevice #insomnia #medtech #innovation #technology #neuroscience #medical 

Our team are getting ready to be a part of LEAP 2024 from 4 - 7 March. Come and talk to us about Modius Sleep, our non-invasive and drug free treatment for Chronic Insomnia. #innovation #medicaldevice #medtech #technology #leap2024 Department for Business and Trade

We're delighted to have been shortlisted for two awards at this years Digital DNA. Looking forward to a great awards night! Best of luck to everyone shortlisted for the various categories. Some great companies, projects and people showcasing fantastic work. #innovation #belfast #medtech #modius

Meet Sinead

"Working for a company that develops non-invasive technology that has a positive impact on people’s health and quality of life is very motivating."

Sinead has been a part of the team at Neurovalens since September 2022. Take a minute or two to get to know what inspires and motivates her as she leads the clinical team.


Arab Health: Day 4

Last chance to try our FDA approved chronic insomnia treatment here at Arab Health Hall 2 G30!

Invest Northern Ireland Invest Northern Ireland - India, Middle East, Africa ABHI Department for Business and Trade Iain Hendrick Jason McKeown Patricia McKeown Sinead Watson

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Google Analytics

HSTS

Content Delivery Network

LetsEncrypt

Clinical and Quality Manager

Rebecca Armstrong

Engineering

Adam Simmons

Healthcare

Rachel Robinson

Jamie Andrews

Ian kerr

Tom Bilyeu

Advisor

Paul McGeoch

CHIEF SCIENTIFIC OFFICER

Kate Willis

Vice President of Commercialization

Jason McKeown

Biotechnology Companies With Less Than $10M in Revenue (Top 10K)

Europe, Middle East, and Africa (EMEA) Companies With Less Than $50M in Revenue (Top 10K)

Biotechnology Companies With Less Than $50M in Revenue (Top 10K)

Companies With Less Than $1B in Revenue (Top 10K)

Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and 
 neurophysiology.Neurovalens has received support from Invest NI under the European Union’s Investment for Growth and Jobs Programme. The project, recorded on the ERDF beneficiaries’ website, will be implemented over the next one year, undertaking research and development activities aimed at improving the competitiveness of the business.

Venture Round - Neurovalens

Non Equity Assistance - Neurovalens

Grant - Neurovalens

Series A - Neurovalens

Equity Crowdfunding - Neurovalens

Seed Round - Neurovalens

Belfast

United Kingdom

Europe

Neurovalens CEO Dr Jason McKeown named visiting Professor at Ulster University

Neurovalens Appoints Kate Willis as Vice President of Commercialization

Neurovalens gets FDA nod for neurostimulator to treat anxiety

Dr Jason McKeown, CEO of Neurovalens, on how his close-knit team continues to tackle global health challenges with ...

Neurovalens secures US approval and closes £2.1m raise

Neurovalens: A novel, non-invasive solution to pervasive health issues

Neurovalens wins FDA nod for anxiety-treating neuromod device, raises $2.65M

United States

North America

France

Romania

India

Asia

HTML5

Vimeo

Cloudflare CDN

Google Fonts

jQuery

Google Maps API

Cardiologs is a competitor of Neurovalens in the health-tech industry, offering innovative solutions in the field of cardiology.

Cardiologs

LifeBank competes with Neurovalens in the health-tech sector, providing solutions for addressing health challenges.

LifeBank

Pager Inc is a competitor of Neurovalens, offering technology-driven healthcare services and solutions.

Pager Inc

Ilara Health Ltd competes with Neurovalens in the health-tech industry, providing innovative healthcare solutions.

Ilara Health Ltd

Cumulus is a primary competitor of Neurovalens, providing competitive solutions in the health-tech industry.

Cumulus

Muse competes with Neurovalens in the health-tech sector, providing innovative solutions for health challenges.

Muse

BrainsWay is a competitor of Neurovalens, offering advanced neurostimulation solutions in the health-tech industry.

BrainsWay

EnteroMedics competes with Neurovalens, providing innovative medical device technologies.

EnteroMedics

Elira is a competitor of Neurovalens, offering advanced solutions in the health-tech industry.

Elira

Aspire Bariatrics competes with Neurovalens, specializing in innovative healthcare solutions for bariatric patients.

Aspire Bariatrics

Neurovalens is a global health-tech company that creates non-invasive neurostimulation products to address some of the world’s greatest health challenges. Their medical device technology offers transdermal activation of the brainstem and hypothalamus, aiming to provide drug-free solutions to health epidemics.

news impact assignment basic	general	May 1, 2024 9:18 PM	22ab99d7
public peers	general	May 1, 2024 9:18 PM	5a92a6dc
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 1, 2024 9:18 PM	5dbe9f46
company summary	general
signals	general
crunchbase trigger	general	Nov 4, 2024 10:53 AM	45b72b71
crunchbase profile	general	Nov 4, 2024 11:22 AM	b3c60f19
li profile	general	May 1, 2024 9:18 PM	a7cd7452
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	561b6f49
peers	general
news basic	general	May 1, 2024 9:18 PM	ce5c731e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:NEUROVALENS

Neurovalens